ALK-Abelló A/S
Budget
€10 — €0
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
None
Mission & Goals
ALK is a Denmark-based, global specialty pharmaceutical company focused on allergy. For over a century, we have been at the forefront of long-term allergy treatment and innovation, working with passion and dedication to help people living with this chronic disease, their families and the healthcare professionals who treat them. Allergy is a widespread, chronic disease impacting and challenging the lives of millions of adults and children globally every day. In fact, it is estimated to affect one in four people in the industrialised world. At ALK, our purpose is to improve the lives of those living with moderate to severe allergies, by continuing to build on our rich legacy of scientific expertise and advancements. We do this by following our strategy, Allergy+, paving the way for us to achieve our goals through focus, innovation, cultivation and optimisation.
EU Legislative Interests
EU initiatives related to pharmaceuticals, e.g. the Biotech Act as well as EUs Life Science strategy
Communication Activities
ALKs communications activites are currently limited to participating in a visit to Bruxelles arranged by Lif - The Danish Pharmaceutical Industry Association on Februar 2nd and 3rd 2026, with planned meetings at: - EFPIA - DG Research & Innovation and DG Internal Market, Industry, Entrepreneurship & SMEs - Meeting with a group of Danish MEPs - Meeting with the Danish permanent representation
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Danish Chamber of Commerce https://www.danskerhverv.dk/engelsk/ LIF - Danish Association of the Pharmaceutical Industry https://www.lif.dk/en/
Organisation Members
The below website contains an exhaustive list of affiliates of ALK-Abelló A/S: https://www.alk.net/affiliate-list
Commissioner Meetings
No recorded meetings with EU commissioners.